- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT02321813
Direct Improvement of Quality of Life Using a Tailored Pathway With Quality of Life Diagnosis and Therapy: Randomised Trial in Colorectal Cancer Patients (DIQOL)
Direct Improvement of Quality of Life Using a Tailored Pathway With Quality of Life Diagnosis and Therapy: Protocol of a Randomised Clinical Trial in Colorectal Cancer Patients
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
There is a growing interest in using quality of life (QoL) data not only as relevant endpoint in clinical trials on cancer patients, but also in routine practice in order to improve patients' health during treatment. The investigators designed, implemented and evaluated an integrated quality of life diagnosis and therapy pathway (QoL pathway) for breast cancer patients (Klinkhammer-Schalke et al, 2008; 2012), guided by the UK Medical Research Council framework for developing and testing complex interventions. It could be demonstrated in a routine setting that breast cancer patients showed a benefit from tailored QoL diagnosis and therapy (Klinkhammer-Schalke et al, 2012).
But there is also requirement for managing QoL deficits of patients with other cancers and to replicate findings of the previous trial. To achieve this aim, the QoL pathway has been modified for colorectal cancer patients. The Tumor Center Regensburg provides the infrastructure of the present project (quality circles, project groups).
This is a two-arm randomised clinical trial with one intervention group and one control group. Patients' QoL is assessed with the EORTC QLQ-C30 and QLQ-CR29 at 0, 3, 6, 12, and 18 months after surgery.
In intervention group results of the QoL-measure are transferred to a QoL-profile including 13 dimensions on scales of 0-100 (cutoff for "diseased QoL <50). Three experts with varying professional background use the individual patient's QoL-profile and clinical and sociodemographic information in order to generate a QoL-report including therapy recommendation which is sent to the coordinating practitioner. Specific therapeutic options for the treatment of diseased QoL have been identified: pain therapy, psychotherapy, social support, nutrition counseling, stoma care, physiotherapy, fitness. To provide continuous medical education, quality circles for each therapy option have been founded. Coordinating practitioners receive a list with addresses of all quality circle members.
In control group QoL is also measured but the coordinating practitioner neither receives a QoL-profile nor a QoL-report.
The investigators expect that patients in the intervention group will experience a lower number of QoL-deficits (QoL < 50 points) in the first year after surgery compared with patients in the control group
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Bavaria
-
Regensburg, Bavaria, Duitsland, 93053
- Tumor Center Regensburg e.V., An-Institute of the University of Regensburg
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- primary colorectal cancer
- operated in one of four participating certified cancer centres for colorectal cancer (Krankenhaus Barmherzige Brüder, Department of Surgery, Regensburg; Germany; Caritas-Krankenhaus St. Josef, Department of Surgery, Regensburg; Germany; Klinikum Neumarkt., Department of Surgery, Neumarkt; Germany; Klinikum St. Elisabeth Straubing, Department of Surgery, Straubing, Germany), documented in a population-based cancer registry (Tumor Center Regensburg e.V.)
- informed consent.
Exclusion Criteria:
- coordinating practitioner not implemented
- patient from district outside the study region (rural districts Regensburg, Neumarkt, Straubing, Straubing-Bogen, Kelheim, Schwandorf)
- patient unable to fill out the questionnaire for physical, psychological or language reasons (including dementia)
- age under 18 years
- pregnancy
- QoL clinician unavailable
- refusal to participate
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Experimenteel: intervention group
In the quality of life pathway results of the quality of life (QoL) measure are transferred to a QoL-profile.
Three experts with various professional background use the individual patient's QoL-profile and clinical and sociodemographic information in order to generate a QoL-report including therapy recommendation which is sent to the coordinating practitioner.
Specific therapeutic options for the treatment of diseased QoL have been identified: pain therapy, psychotherapy, social support, nutrition counseling, stoma care, physiotherapy, fitness.
To provide continuous medical education, quality circles for each therapy option haven been founded.
Coordinating practitioners receive a list with addresses of all quality circle members.
|
Quality of life measurement, diagnosis and tailored therapy (pain therapy, psychotherapy, social support, nutrition, stoma care, physiotherapy, fitness)
|
Placebo-vergelijker: control group
In control group QoL is also measured but the coordinating practitioner neither receives a QoL-profile nor a QoL-report.
|
Quality of life measurement
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
---|---|
proportion of patients in both groups with diseased quality of life (<50 points in at least one dimension)
Tijdsspanne: 1 year after the date of primary surgery for colorectal cancer
|
1 year after the date of primary surgery for colorectal cancer
|
Secundaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
---|---|
rates of patients with diseased quality of life in each dimension of the profile
Tijdsspanne: 0 (0-2 days before clinical discharge), 3, 6, 12, and 18 months after primary surgery for colorectal cancer
|
0 (0-2 days before clinical discharge), 3, 6, 12, and 18 months after primary surgery for colorectal cancer
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Studie stoel: Monika Klinkhammer-Schalke, MD, Ass. Prof., Tumor Center Regensburg e.V., An-Institute of the University of Regensburg, Germany
- Hoofdonderzoeker: Michael Koller, Ph.D., Prof., Center for Clinical Trials, University Regensburg, Germany
- Hoofdonderzoeker: Wilfried Lorenz, MD, Prof. Ɨ, Tumor Center Regensburg e.V., An-Institute of the University of Regensburg, Germany
- Hoofdonderzoeker: Ferdinand Hofstädter, MD, Prof., Johannes Kepler University Linz, Medical Faculty, Austria
- Hoofdonderzoeker: Jeremy C Wyatt, MD, Prof., Leeds Institute of Health Sciences, University of Leeds, UK
Publicaties en nuttige links
Algemene publicaties
- Klinkhammer-Schalke M, Koller M, Steinger B, Ehret C, Ernst B, Wyatt JC, Hofstadter F, Lorenz W; Regensburg QoL Study Group. Direct improvement of quality of life using a tailored quality of life diagnosis and therapy pathway: randomised trial in 200 women with breast cancer. Br J Cancer. 2012 Feb 28;106(5):826-38. doi: 10.1038/bjc.2012.4. Epub 2012 Feb 7.
- Klinkhammer-Schalke M, Koller M, Ehret C, Steinger B, Ernst B, Wyatt JC, Hofstadter F, Lorenz W; Regensburg QoL Study Group. Implementing a system of quality-of-life diagnosis and therapy for breast cancer patients: results of an exploratory trial as a prerequisite for a subsequent RCT. Br J Cancer. 2008 Aug 5;99(3):415-22. doi: 10.1038/sj.bjc.6604505.
- Klinkhammer-Schalke M, Koller M, Wyatt JC, Steinger B, Ehret C, Ernst B, Hofstadter F, Lorenz W. Quality of life diagnosis and therapy as complex intervention for improvement of health in breast cancer patients: delineating the conceptual, methodological, and logistic requirements (modeling). Langenbecks Arch Surg. 2008 Jan;393(1):1-12. doi: 10.1007/s00423-007-0210-5. Epub 2007 Jul 28.
- Klinkhammer-Schalke M, Steinger B, Koller M, Zeman F, Furst A, Gumpp J, Obermaier R, Piso P, Lindberg-Scharf P; Regensburg QoL Study Group. Diagnosing deficits in quality of life and providing tailored therapeutic options: Results of a randomised trial in 220 patients with colorectal cancer. Eur J Cancer. 2020 May;130:102-113. doi: 10.1016/j.ejca.2020.01.025. Epub 2020 Mar 13.
- Klinkhammer-Schalke M, Lindberg P, Koller M, Wyatt JC, Hofstadter F, Lorenz W, Steinger B. Direct improvement of quality of life in colorectal cancer patients using a tailored pathway with quality of life diagnosis and therapy (DIQOL): study protocol for a randomised controlled trial. Trials. 2015 Oct 14;16:460. doi: 10.1186/s13063-015-0972-y.
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- TUZ-QL-CRC-14
- 01GY1339 (Ander subsidie-/financieringsnummer: German Federal Ministry of Education and Research)
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Kwaliteit van het leven
-
Rambam Health Care CampusOnbekendom LIF-niveau in navelstrengbloed van embryo's die IUGR zijn te vergelijken met degenen die AGA zijn
Klinische onderzoeken op quality of life pathway
-
NLT SpineOnbekendDegeneratieve schijfziekteIsraël
-
KU LeuvenDublin City UniversityVoltooidHart-en vaatziekteIerland, België
-
Pathway Medical Technologies Inc.VoltooidPerifere arteriële ziekte | Perifere vaatziekteVerenigde Staten
-
Pathway Medical Technologies Inc.VoltooidPerifere slagaderziekte
-
Mazor RoboticsVoltooidOnder rug pijnDuitsland, Israël
-
Advocate Health CareTakeda; Lundbeck LLCVoltooidErnstige depressieve stoornisVerenigde Staten
-
San Diego Veterans Healthcare SystemPathway Genomics CorpOnbekend
-
Genentech, Inc.National Cancer Institute (NCI); Sidney Kimmel Comprehensive Cancer Center at...VoltooidNiet-gespecificeerde volwassen solide tumor, protocolspecifiek
-
Wake Forest University Health SciencesDuke UniversityVoltooidVervroegde zorgplanningVerenigde Staten